Skip to main content

BGI, Novo Nordisk Partner to Create Collaborative Framework

NEW YORK (GenomeWeb News) – BGI and Novo Nordisk today announced a collaboration to create a "global collaboration framework."

The two firms provided few details about the agreement but said that it would create an opportunity for them to "accelerate their growth, execute their global partnering strategy and support disease research and development efforts." BGI will contribute its next-generation sequencing platforms and bioinformatics capabilities, and Novo Nordisk will contribute its drug development expertise.

Financial and other terms were not disclosed.

Last month BGI officially opened its European Genome Research Center in Denmark, where Novo Nordisk is heaquartered, and in a statement today Ning Li, director of BGI Europe, said it would provide "an excellent platform for us and our collaborators."

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.